Perceiv AI Welcomes Simona Skerjanec to Board of Directors
Thought Leader in Brain Health Joins Richard Stark and Company Co-Founders to Accelerate Innovation in Precision MedicineMONTREAL, QC / ACCESSWIRE...
Pharmaceutical
NanoViricides President Dr. Diwan Interviwed in PODD Podcast; He Explains the Revolutionary Clinical Stage Broad-Spectrum Antiviral NV-387, and the Potential of the Platform to Revolutionize Fields Beyond Virology
SHELTON, CT / ACCESSWIRE / October 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader...
SELLAS Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to Galinpepimut-S (GPS) for the Treatment of Pediatric Acute Myeloid Leukemia
- GPS Currently Investigated in Phase 3 REGAL Trial in Adult AML Patients – Interim Analysis Anticipated in Q4 2024...
Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler
BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of...
scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024
Webinar to focus on a nephrologist’s perspective on the use of FUROSCIX for fluid overload in heart failure and potential...
89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at AASLD The Liver Meeting® 2024
SAN FRANCISCO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development...
Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit
DENVER, CO / ACCESSWIRE / October 14, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company...
Germfree acquires Arcoplast to expand turnkey facility solutions and expand market reach through superior architectural finishes
Arcoplast's unmatched architectural finishes meet the highest standards for cleanability, durability, and sustainability for controlled environmentsAcquisition supports Germfree's expansion beyond...
Laxxon Medical to Present Innovative Oral GLP-1 Agonist with Multi-Compartment Micro-Tablet Form, Aiming to Enhance Patient Compliance for Special Patient Groups, at the 2024 BIO Europe Convention
NEW YORK, NY / ACCESSWIRE / October 4, 2024 / Laxxon Medical, a US-based pharma-technology company pioneering a new generation...
GE HealthCare introduces easy-to-use, easy-to-learn, easy-to-diagnose Versana Premier multi-purpose ultrasound system
Versana Premier is designed to feel familiar from day one, simplifying workflow and making it easier for clinicians in multiple-purpose...
Glaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual Meeting
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the...
Aprea Therapeutics to Present at Maxim 2024 Healthcare Virtual Summit
DOYLESTOWN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company...
Zhejiang Taimei Medical Technology Co., Ltd. Is Now Listed on HKEX
HONG KONG, Oct. 13, 2024 /PRNewswire/ -- Zhejiang Taimei Medical Technology Co., Ltd. (the "Company"; Stock code: 2576.HK) has announced that...
Quest PharmaTech Announces Results from AGM
EDMONTON, Alberta, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results...
Nelipak Healthcare Packaging Awarded Silver Medal Sustainability Rating from EcoVadis for Second Consecutive Year
Nelipak Ranked Among the Top 15% of Surveyed CompaniesCRANSTON, R.I., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Nelipak Corporation (“Nelipak”), a...
Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week
WATERTOWN, Mass., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,...
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage...
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024
LAKE FOREST, Ill., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical...
Better Choice Company to Expand into Veterinary Medicine in 2025 Following the Acquisition of SRx Health
TAMPA, Fla., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet...
Sagimet Biosciences Announces Publication of Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 MASH in The Lancet Gastroenterology & Hepatology
- Treatment with denifanstat achieved statistically significant and clinically meaningful improvements in disease activity, MASH resolution and fibrosis -- Results...